Suppressor of cytokine signaling 2 regulates IL-15-primed human NK cell function via control of phosphorylated Pyk2

Journal of Immunology

Volumn 185, Issue 2, 2010, Pages 917-928

  Lee, Suk Hyung ^a,b   Yun, Sohyun ^a   Piao, Zheng Hao ^a   Jeong, Mira ^a,b   Kim, Dong Oh ^a,b   Jung, Haiyoung ^a   Lee, Jiwon ^a,b   Kim, Mi Jeong ^a   Kim, Mi Sun ^a   Chung, Jin Woong ^c   Kim, Tae Don ^a,b   Yoon, Suk Ran ^a   Greenberg, Philip D ^d,e   Choi, Inpyo ^a,b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

^c Dong A University   (South Korea)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE 2; GAMMA INTERFERON; INTERLEUKIN 15; SUPPRESSOR OF CYTOKINE SIGNALING 2; TYROSINE; INTERLEUKIN 15 RECEPTOR; SOCS2 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL SURVIVAL; CYTOLYSIS; CYTOTOXICITY; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UBIQUITINATION; UPREGULATION; CELL CULTURE; CELL LINE; CELL STRAIN K 562; DRUG EFFECT; GENETICS; IMMUNOLOGY; LEUKEMIA CELL LINE; METABOLISM; MUTATION; NEWBORN; PHOSPHORYLATION; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; FOCAL ADHESION KINASE 2; HUMANS; INFANT, NEWBORN; INTERFERON-GAMMA; INTERLEUKIN-15; JURKAT CELLS; K562 CELLS; KILLER CELLS, NATURAL; MUTATION; PHOSPHORYLATION; PROTEIN BINDING; RECEPTORS, INTERLEUKIN-15; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TYROSINE;

EID: 77955484577     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000784     Document Type: Article

References (45)

1. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47: 187-376.
2. Cerwenka, A., and L. L. Lanier. 2001. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1: 41-49.
3. Berke, G. 1997. Killing mechanisms of cytotoxic lymphocytes. Curr. Opin. Hematol. 4: 32-40.
4. Trambas, C. M., and G. M. Griffiths. 2003. Delivering the kiss of death. Nat. Immunol. 4: 399-403.
5. Voskoboinik, I., M. J. Smyth, and J. A. Trapani. 2006. Perforin-mediated target-cell death and immune homeostasis. Nat. Rev. Immunol. 6: 940-952.
6. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17: 189-220.
7. Zompi, S., J. A. Hamerman, K. Ogasawara, E. Schweighoffer, V. L. Tybulewicz, J. P. Di Santo, L. L. Lanier, and F. Colucci. 2003. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases. Nat. Immunol. 4: 565-572.
8. Filipe-Santos, O., J. Bustamante, A. Chapgier, G. Vogt, L. de Beaucoudrey, J. Feinberg, E. Jouanguy, S. Boisson-Dupuis, C. Fieschi, C. Picard, and J. L. Casanova. 2006. Inborn errors of IL-12/23- and IFN-γ-mediated immunity: molecular, cellular, and clinical features. Semin. Immunol. 18: 347-361.
9. low targets prime dendritic cells to induce protective CD8 T cell responses. Immunity 19: 561-569.
10. Maher, S. G., A. L. Romero-Weaver, A. J. Scarzello, and A. M. Gamero. 2007. Interferon: cellular executioner or white knight? Curr. Med. Chem. 14: 1279-1289.
11. Bryceson, Y. T., M. E. March, H. G. Ljunggren, and E. O. Long. 2006. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107: 159-166.
12. Becknell, B., and M. A. Caligiuri. 2005. Interleukin-2, interleukin-15, and their roles in human natural killer cells. Adv. Immunol. 86: 209-239.
13. Lucas, M., W. Schachterle, K. Oberle, P. Aichele, and A. Diefenbach. 2007. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26: 503-517. (Pubitemid 46602996)
14. Yoshimura, A., T. Naka, and M. Kubo. 2007. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7: 454-465.
15. Rico-Bautista, E., A. Flores-Morales, and L. Fernández- Pérez. 2006. Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions. Cytokine Growth Factor Rev. 17: 431-439.
16. Alexander, W. S., and D. J. Hilton. 2004. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu. Rev. Immunol. 22: 503-529.
17. Favre, H., A. Benhamou, J. Finidori, P. A. Kelly, and M. Edery. 1999. Dual effects of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction. FEBS Lett. 453: 63-66. (Pubitemid 29335474)
18. Machado, F. S., L. Esper, A. Dias, R. Madan, Y. Gu, D. Hildeman, C. N. Serhan, C. L. Karp, and J. Aliberti. 2008. Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6. [Retraction appears in 2009 J. Exp. Med. 206: 2573.] J. Exp. Med. 205: 1077-1086.
19. Kang, H. S., E. M. Kim, S. Lee, S. R. Yoon, T. Kawamura, Y. C. Lee, S. Kim, P. K. Myung, S. M. Wang, and I. Choi. 2005. Stage-dependent gene expression profiles during natural killer cell development. Genomics 86: 551-565. (Pubitemid 41416788)
20. Yoshimura, A., H. Nishinakamura, Y. Matsumura, and T. Hanada. 2005. Negative regulation of cytokine signaling and immune responses by SOCS proteins. Arthritis Res. Ther. 7: 100-110.
21. Kennedy, M. K., M. Glaccum, S. N. Brown, E. A. Butz, J. L. Viney, M. Embers, N. Matsuki, K. Charrier, L. Sedger, C. R. Willis, et al. 2000. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191: 771-780.
22. Cooper, M. A., J. E. Bush, T. A. Fehniger, J. B. VanDeusen, R. E. Waite, Y. Liu, H. L. Aguila, and M. A. Caligiuri. 2002. In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood 100: 3633-3638.
23. Huntington, N. D., H. Puthalakath, P. Gunn, E. Naik, E. M. Michalak, M. J. Smyth, H. Tabarias, M. A. Degli-Esposti, G. Dewson, S. N. Willis, et al. 2007. Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1. Nat. Immunol. 8: 856-863.
24. c-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol. Rev. 202: 67-83.
25. Vivier, E., J. A. Nunès, and F. Vély. 2004. Natural killer cell signaling pathways. Science 306: 1517-1519. (Pubitemid 39564941)
26. Vyas, Y. M., H. Maniar, and B. Dupont. 2002. Visualization of signaling pathways and cortical cytoskeleton in cytolytic and noncytolytic natural killer cell immune synapses. Immunol. Rev. 189: 161-178.
27. Jiang, K., B. Zhong, D. L. Gilvary, B. C. Corliss, E. Hong-Geller, S. Wei, and J. Y. Djeu. 2000. Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nat. Immunol. 1: 419-425.
28. Chen, X., D. S. Allan, K. Krzewski, B. Ge, H. Kopcow, and J. L. Strominger. 2006. CD28-stimulated ERK2 phosphorylation is required for polarization of the microtubule organizing center and granules in YTS NK cells. Proc. Natl. Acad. Sci. USA 103: 10346-10351.
29. Li, C., B. Ge, M. Nicotra, J. N. Stern, H. D. Kopcow, X. Chen, and J. L. Strominger. 2008. JNK MAP kinase activation is required for MTOC and granule polarization in NKG2D-mediated NK cell cytotoxicity. Proc. Natl. Acad. Sci. USA 105: 3017-3022.
30. Melchjorsen, J., L. N. Sørensen, and S. R. Paludan. 2003. Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function. J. Leukoc. Biol. 74: 331-343.
31. Dong, C., R. J. Davis, and R. A. Flavell. 2002. MAP kinases in the immune response. Annu. Rev. Immunol. 20: 55-72.
32. Szabo, S. J., B. M. Sullivan, S. L. Peng, and L. H. Glimcher. 2003. Molecular mechanisms regulating Th1 immune responses. Annu. Rev. Immunol. 21: 713-758.
33. Hesslein, D. G., R. Takaki, M. L. Hermiston, A. Weiss, and L. L. Lanier. 2006. Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production. Proc. Natl. Acad. Sci. USA 103: 7012-7017.
34. Fassett, M. S., D. M. Davis, M. M. Valter, G. B. Cohen, and J. L. Strominger. 2001. Signaling at the inhibitory natural killer cell immune synapse regulates lipid raft polarization but not class I MHC clustering. Proc. Natl. Acad. Sci. USA 98: 14547-14552.
35. Sancho, D., M. Nieto, M. Llano, J. L. Rodríguez-Fernández, R. Tejedor, S. Avraham, C. Cabañas, M. López-Botet, and F. Sánchez-Madrid. 2000. The tyrosine kinase PYK-2/RAFTK regulates natural killer (NK) cell cytotoxic response, and is translocated and activated upon specific target cell recognition and killing. J. Cell Biol. 149: 1249-1262.
36. Waldmann, T. A. 2006. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 6: 595-601.
37. Long, E. O. 2007. Ready for prime time: NK cell priming by dendritic cells. Immunity 26: 385-387.
38. Liu, E., J. F. Côté, and K. Vuori. 2003. Negative regulation of FAK signaling by SOCS proteins. EMBO J. 22: 5036-5046. (Pubitemid 37222024)
39. Gismondi, A., J. Jacobelli, F. Mainiero, R. Paolini, M. Piccoli, L. Frati, and A. Santoni. 2000. Cutting edge: functional role for proline-rich tyrosine kinase 2 in NK cell-mediated natural cytotoxicity. J. Immunol. 164: 2272-2276. (Pubitemid 30115451)
40. Gismondi, A., J. Jacobelli, R. Strippoli, F. Mainiero, A. Soriani, L. Cifaldi, M. Piccoli, L. Frati, and A. Santoni. 2003. Proline-rich tyrosine kinase 2 and Rac activation by chemokine and integrin receptors controls NK cell transendothelial migration. J. Immunol. 170: 3065-3073. (Pubitemid 36302181)
41. Khaled, A. R., and S. K. Durum. 2002. Lymphocide: cytokines and the control of lymphoid homeostasis. Nat. Rev. Immunol. 2: 817-830.
42. 1 integrin fibronectin receptor cross-linking and association with paxillin in human natural killer cells. J. Immunol. 159: 4729-4736.
43. 3 integrin-mediated signaling, cell adhesion, and osteoclast motility. J. Cell Biol. 152: 181-195.
44. 3 integrin, and phosphorylated by src kinase. J. Clin. Invest. 102: 881-892.
45. Zhang, Z., L. Neff, A. L. Bothwell, R. Baron, and W. C. Horne. 2002. Calcitonin induces dephosphorylation of Pyk2 and phosphorylation of focal adhesion kinase in osteoclasts. Bone 31: 359-365.